Nicholas Saccomano is President and Chief Executive Officer of OnKure Therapeutics, Inc. (OKUR). The company reported total compensation of $1,467,934 for fiscal year 2025.
| Salary | $600,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $609,934 |
| Non-equity incentive plan | $247,500 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,500 |
| Total | $1,467,934 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure OnKure Therapeutics, Inc. filed April 21, 2026, accession 0001140361-26-015903.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $600,000 | $0 | $0 | $609,934 | $247,500 | $0 | $10,500 | $1,467,934 |
| FY2024 | President and Chief Executive Officer | $462,145 | $0 | $0 | $8,773,422 | $279,598 | $0 | $0 | $9,515,165 |
Totals as disclosed in each year's own compensation disclosure for OnKure Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Nicholas Saccomano this page | President and Chief Executive Officer | $1,467,934 |
| Jason Leverone | Chief Financial Officer | $896,167 |
| Samuel Agresta | Chief Medical Officer | $851,731 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full OnKure Therapeutics, Inc. compensation brief.
Nicholas Saccomano's compensation sits inside OnKure Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.